✦ LIBER ✦

Development of peptide antagonists that target estrogen receptor–cofactor interactions

✍ Scribed by Donald P. McDonnell; Ching-Yi Chang; John D. Norris

Book ID: 117668053
Publisher: Elsevier Science
Year: 2000
Tongue: English
Weight: 375 KB
Volume: 74
Category: Article
ISSN: 0960-0760
DOI: 10.1016/s0960-0760(00)00109-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

An on-bead assay for the identification

An on-bead assay for the identification of non-natural peptides targeting the Androgen Receptor–cofactor interaction

✍ Hülya Göksel; Dorothee Wasserberg; Sabine Möcklinghoff; Belen Vaz Araujo; Luc Br 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 374 KB

‘Targeted’ molecular diversity: design a

‘Targeted’ molecular diversity: design and development of non-peptide antagonists for cholecystokinin and tachykinin receptors

✍ David Horwell; Martyn Pritchard; Jennifer Raphy; Giles Ratcliffe 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 313 KB

Development of a Bioavailable μ Opioid R

Development of a Bioavailable μ Opioid Receptor (MOPr) Agonist, δ Opioid Receptor (DOPr) Antagonist Peptide That Evokes Antinociception without Development of Acute Tolerance

✍ Mosberg, Henry I.; Yeomans, Larisa; Anand, Jessica P.; Porter, Vanessa; Sobczyk- 📂 Article 📅 2014 🏛 American Chemical Society 🌐 English ⚖ 278 KB

Inhibition of 1,25-Dihydroxyvitamin D3-D

Inhibition of 1,25-Dihydroxyvitamin D3-Dependent Transcription by Synthetic LXXLL Peptide Antagonists that Target the Activation Domains of the Vitamin D and Retinoid X Receptors

✍ Peterson Pathrose; Olga Barmina; Ching-Yi Chang; Donald P. McDonnell; Nirupama K 📂 Article 📅 2002 🏛 American Society for Bone and Mineral Research 🌐 English ⚖ 666 KB